NJ| Bulletin NO. 25-07, from the New Jersey Department of Banking and Insurance provides updated guidance on COVID-19 vaccine coverage for the 2025-2026 respiratory illness season. It affirms that all state-regulated health insurance carriers must continue covering COVID-19 vaccines and their administration without cost-sharing, in alignment with state law and recent directives from health authorities.
Key Points:
- Carriers are expected to provide coverage for FDA-approved COVID-19 vaccines for all individuals according to New Jersey Department of Health recommendations, with no barriers such as additional prescriptions or proof of underlying conditions, and must update all related documents and online information accordingly.
- Entities administering self-funded or non-state regulated plans are encouraged to inform plan sponsors about these requirements and promote adherence to state guidelines for vaccine access in New Jersey.
